medica 16 has been researched along with 1-anilino-8-naphthalenesulfonate in 1 studies
| Studies (medica 16) | Trials (medica 16) | Recent Studies (post-2010) (medica 16) | Studies (1-anilino-8-naphthalenesulfonate) | Trials (1-anilino-8-naphthalenesulfonate) | Recent Studies (post-2010) (1-anilino-8-naphthalenesulfonate) |
|---|---|---|---|---|---|
| 35 | 0 | 4 | 24,275 | 480 | 7,815 |
| Protein | Taxonomy | medica 16 (IC50) | 1-anilino-8-naphthalenesulfonate (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Tana, J; Frenkel, B; Hertz, R; Mayorek, N | 1 |
1 other study(ies) available for medica 16 and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
The hypochylomicronemic effect of beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III.
Topics: Animals; Apolipoprotein C-III; Apolipoproteins C; Chylomicrons; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins, LDL; Liver; Lymph; Male; Palmitic Acids; Rats | 1988 |